Literature DB >> 30217697

Overexpression of GP73 promotes cell invasion, migration and metastasis by inducing epithelial-mesenchymal transition in pancreatic cancer.

Yin-Xue Song1, Zhi-Chao Xu1, Hui-Ling Li1, Pei-Lei Yang1, Jun-Kai Du1, Jing Xu2.   

Abstract

Pancreatic cancer is one of the most difficult clinical cases to diagnose with a very low 5-year survival rate of 5%, regardless of the advances made in both the medical and surgical treatment of the disease. One of the contributing factors for the high mortality rate seen of pancreatic cancer patients is the lack of effective chemotherapies, which is believed to be due to drug-resistance. Based on recent evidence, epithelial-mesenchymal transition (ETM) of pancreatic cancer cells has been found to be associated with the development of drug resistance and an increase in cell invasion. Therefore, we conducted the present study in order to investigate the regulatory effects of Golgi protein-73 (GP73) on PC. GP73 and EMT-related gene expressions in PC, along with the adjacent and chronic pancreatitis tissues were determined by means of RT-qPCR and Western blot analysis. Cultured PC cells were treated with pAdTrack-CMV, si-NC, GP73 overexpression, Si-GP73, Snail-siRNA and GP73 + Snail-siRNA. Cell invasion, migration and metastasis were measured in vitro and in vivo. The results revealed that the PC tissues and chronic pancreatitis tissues exhibited diminished E-cadherin expression and amplified GP73, N-cadherin, Vimentin and Snail expression. In response to GP73 gene silencing, PC cells presented with increased E-cadherin expression and decreased N-cadherin, Vimentin, Snail expression in addition to the inhibition of the number of invasive cells, tumor volume and number of liver lesions. These findings highly indicated that the overexpression of GP73 promotes cell invasion, migration and metastasis by inducing EMT in PC.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Epithelial-mesenchymal transition; Golgi protein-73; Invasion; Metastasis; Migration; Pancreatic cancer

Mesh:

Substances:

Year:  2018        PMID: 30217697     DOI: 10.1016/j.pan.2018.08.009

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  5 in total

1.  LNC00673 suppresses proliferation and metastasis of pancreatic cancer via target miR-504/ HNF1A.

Authors:  Yi Gong; Hai-Su Dai; Jun-Jie Shu; Wei Liu; Ping Bie; Lei-da Zhang
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

2.  Knockdown of Golgi phosphoprotein 73 blocks the trafficking of matrix metalloproteinase-2 in hepatocellular carcinoma cells and inhibits cell invasion.

Authors:  Yiming Liu; Xiaodi Zhang; Sining Zhou; Jieyao Shi; Yun Xu; Jia He; Feng Lin; Anbang Wei; Linfu Zhou; Zhi Chen
Journal:  J Cell Mol Med       Date:  2019-01-24       Impact factor: 5.310

Review 3.  Targeting Epithelial Mesenchymal Plasticity in Pancreatic Cancer: A Compendium of Preclinical Discovery in a Heterogeneous Disease.

Authors:  James H Monkman; Erik W Thompson; Shivashankar H Nagaraj
Journal:  Cancers (Basel)       Date:  2019-11-07       Impact factor: 6.639

4.  Golgi protein 73, hepatocellular carcinoma and other types of cancers.

Authors:  Yanan Wang; Yu-Jui Yvonne Wan
Journal:  Liver Res       Date:  2020-09-25

Review 5.  Golgi Phosphoprotein 73: The Driver of Epithelial-Mesenchymal Transition in Cancer.

Authors:  Yiming Liu; Xinyang Hu; Shiyao Liu; Sining Zhou; Zhi Chen; Hongchuan Jin
Journal:  Front Oncol       Date:  2021-12-07       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.